---
figid: PMC3779382__328f2
figlink: /pmc/articles/PMC3779382/figure/F2/
number: F2
caption: Schematic diagram of EBV-mediated oncogenic signaling pathway activation
  in EBV-positive diffuse large B-cell lymphoma of the elderly. LMP1 has a 6-transmembrane
  domain with a long cytoplasmic C-terminal chain. It can self-aggregate to activate
  itself constitutively and provide a platform to interact with downstream molecules.
  LMP1 provides a proliferation signal via activating NF-κB, PI3K/Akt, MEK-ERK, and
  JNK–AP-1 MAPK pathways. It also gives signal for cell cycle progression by enhancing
  cyclin-dependent kinase 2 and phosphorylation of Rb protein and by inhibiting p16
  and p27. LMP1 can also activate bcl-2 to provide an antiapoptotic signal. CTAR1
  can directly interact with TRAF1, 2, 3, and 5 to activate NF-κB, PI3K/Akt, MEK-ERK,
  and JNK–AP-1 MAPK pathways. CTAR2 needs TRADD to interact with TRAF2 to activate
  NF-κB. Both canonical and noncanonical pathways of NF-κB are activated to give proliferation
  signal to the nucleus. There are 3 putative JAK3-binding motifs between CTAR1 and
  CTAR2. However, this finding was not reproduced by others.- AP-1, activator protein
  1; ERK, extracellular signal-regulated kinases; JAK3, Janus kinase 3; JNK, Jun amino-terminal
  kinases; MEK, MAPK/ERK kinase; PI3K, phosphatidylinositol 3-kinase; TRADD, tumor
  necrosis factor receptor type 1–associated DEATH domain; TRAF, tumor necrosis factor
  receptor–associated factor.
pmcid: PMC3779382
papertitle: EBV-positive diffuse large B-cell lymphoma of the elderly.
reftext: Chi Young Ok, et al. Blood. 2013 Jul 18;122(3):328-340.
pmc_ranked_result_index: '65031'
pathway_score: 0.9717084
filename: 328f2.jpg
figtitle: EBV-mediated oncogenic signaling pathway activation in EBV-positive diffuse
  large B-cell lymphoma of the elderly
year: '2013'
organisms: Homo sapiens
ndex: 806ae4de-deb4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3779382__328f2.html
  '@type': Dataset
  description: Schematic diagram of EBV-mediated oncogenic signaling pathway activation
    in EBV-positive diffuse large B-cell lymphoma of the elderly. LMP1 has a 6-transmembrane
    domain with a long cytoplasmic C-terminal chain. It can self-aggregate to activate
    itself constitutively and provide a platform to interact with downstream molecules.
    LMP1 provides a proliferation signal via activating NF-κB, PI3K/Akt, MEK-ERK,
    and JNK–AP-1 MAPK pathways. It also gives signal for cell cycle progression by
    enhancing cyclin-dependent kinase 2 and phosphorylation of Rb protein and by inhibiting
    p16 and p27. LMP1 can also activate bcl-2 to provide an antiapoptotic signal.
    CTAR1 can directly interact with TRAF1, 2, 3, and 5 to activate NF-κB, PI3K/Akt,
    MEK-ERK, and JNK–AP-1 MAPK pathways. CTAR2 needs TRADD to interact with TRAF2
    to activate NF-κB. Both canonical and noncanonical pathways of NF-κB are activated
    to give proliferation signal to the nucleus. There are 3 putative JAK3-binding
    motifs between CTAR1 and CTAR2. However, this finding was not reproduced by others.-
    AP-1, activator protein 1; ERK, extracellular signal-regulated kinases; JAK3,
    Janus kinase 3; JNK, Jun amino-terminal kinases; MEK, MAPK/ERK kinase; PI3K, phosphatidylinositol
    3-kinase; TRADD, tumor necrosis factor receptor type 1–associated DEATH domain;
    TRAF, tumor necrosis factor receptor–associated factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT3
  - MAPK10
  - AKT1
  - STAT2
  - JAK3
  - AKT3
  - STAT1
  - BCL2
  - JAK2
  - STAT4
  - AKT2
  - CDK2
  - PIK3R6
  - JAK1
  - CDKN2A
  - MAPK8
  - STAT5A
  - STAT5B
  - MAPK9
  - PIK3CB
  - TRAF5
  - TRAF2
  - PIK3R3
  - TRAF1
  - PIK3R5
  - PIK3CD
  - TRADD
  - MAPK1
  - TYK2
  - TRAF3
  - PIK3CA
  - PIK3R4
  - MAPK3
  - STAT6
  - PIK3CG
  - MAP2K2
  - NFKB1
  - MAP2K1
  - Cancer
genes:
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Cdk2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TRAF5
  symbol: TRAF5
  source: hgnc_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: TRAF1
  symbol: TRAF1
  source: hgnc_symbol
  hgnc_symbol: TRAF1
  entrez: '7185'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TRADD
  symbol: TRADD
  source: hgnc_symbol
  hgnc_symbol: TRADD
  entrez: '8717'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3779382__F2
redirect_from: /figures/PMC3779382__F2
figtype: Figure
---
